Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association.
Volkan IzolFesih OkGuven AslanBulent AkdoganSinan SozenEnder OzdenOrcun CelikTalha MuezzinogluLevent TurkeriNebil AkdoğanSumer BaltaciPublished in: The Prostate (2022)
Overall and cancer-specific survival analyzes were not evaluated because not enough events were observed. Neither PLND nor its extent improved BCRFS outcomes in IRPC. The LNI rate is low in patients with biopsy ISUP grade 2 and the BCR rate is low in those with PSA < 7.81 ng/dl so PLND can be omitted in these IRPC patients.
Keyphrases
- prostate cancer
- rectal cancer
- radical prostatectomy
- end stage renal disease
- ejection fraction
- newly diagnosed
- palliative care
- chronic kidney disease
- lymph node
- robot assisted
- prognostic factors
- papillary thyroid
- type diabetes
- patient reported outcomes
- squamous cell
- young adults
- benign prostatic hyperplasia
- metabolic syndrome
- chronic myeloid leukemia